$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl

$bdrl Overview Financials Valuation SEC Filings Company Website

2013 Q3 Form 10-Q Financial Statement

#000114420413061383 Filed on November 14, 2013

Income Statement

Concept	2013 Q3	2012 Q3
Revenue	$6.823M	$8.610M
YoY Change	-20.75%	23.0%
Cost Of Revenue	$4.550M	$5.300M
YoY Change	-14.15%	15.97%
Gross Profit	$2.273M	$3.310M
YoY Change	-31.33%	36.21%
Gross Profit Margin	33.31%	38.44%
Selling, General & Admin	$2.117M	$2.320M
YoY Change	-8.75%	31.82%
% of Gross Profit	93.14%	70.09%
Research & Development	$780.0K	$820.0K
YoY Change	-4.88%	20.59%
% of Gross Profit	34.32%	24.77%
Depreciation & Amortization	$310.0K	$350.0K
YoY Change	-11.43%	12.9%
% of Gross Profit	13.64%	10.57%
Operating Expenses	$2.897M	$3.130M
YoY Change	-7.44%	28.28%
Operating Profit	-$624.0K	$180.0K
YoY Change	-446.67%	-1900.0%
Interest Expense	$64.00K	-$90.00K
YoY Change	-171.11%	125.0%
% of Operating Profit		-50.0%
Other Income/Expense, Net	-$64.00K
YoY Change
Pretax Income	-$688.0K	$90.00K
YoY Change	-864.44%	-280.0%
Income Tax	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$688.0K	$90.00K
YoY Change	-864.44%	-280.0%
Net Earnings / Revenue	-10.08%	1.05%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.11	$0.01
COMMON SHARES
Basic Shares Outstanding	6.216M shares
Diluted Shares Outstanding	6.216M shares

Balance Sheet

Concept	2013 Q3	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$50.00K	$170.0K
YoY Change	-70.59%	-89.17%
Cash & Equivalents	$54.00K	$170.0K
Short-Term Investments
Other Short-Term Assets	$910.0K	$1.340M
YoY Change	-32.09%	39.58%
Inventory	$9.320M	$10.90M
Prepaid Expenses
Receivables	$2.870M	$4.610M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$13.16M	$17.03M
YoY Change	-22.72%	16.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.766M	$4.060M
YoY Change	-7.24%	4.37%
Goodwill	$493.0K
YoY Change
Intangibles	$483.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$168.0K	$6.270M
YoY Change	-97.32%	-19.72%
Total Long-Term Assets	$9.748M	$13.89M
YoY Change	-29.82%	10.41%
TOTAL ASSETS
Total Short-Term Assets	$13.16M	$17.03M
Total Long-Term Assets	$9.748M	$13.89M
Total Assets	$22.91M	$30.92M
YoY Change	-25.91%	13.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$942.0K	$1.860M
YoY Change	-49.35%	73.83%
Accrued Expenses	$1.500M	$1.620M
YoY Change	-7.41%	78.02%
Deferred Revenue
YoY Change
Short-Term Debt	$1.190M	$3.500M
YoY Change	-66.0%
Long-Term Debt Due	$274.0K	$270.0K
YoY Change	1.48%	3.85%
Total Short-Term Liabilities	$3.920M	$7.300M
YoY Change	-46.3%	218.78%
LONG-TERM LIABILITIES
Long-Term Debt	$3.959M	$4.210M
YoY Change	-5.96%	45.67%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$3.959M	$4.210M
YoY Change	-5.96%	45.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.920M	$7.300M
Total Long-Term Liabilities	$3.959M	$4.210M
Total Liabilities	$7.879M	$11.51M
YoY Change	-31.55%	122.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.202M
YoY Change
Common Stock	$26.13M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$7.308M
YoY Change
Treasury Stock Shares	2.248M shares
Shareholders Equity	$15.00M	$19.42M
YoY Change
Total Liabilities & Shareholders Equity	$22.91M	$30.92M
YoY Change	-25.91%	13.93%

Cashflow Statement

Concept	2013 Q3	2012 Q3
OPERATING ACTIVITIES
Net Income	-$688.0K	$90.00K
YoY Change	-864.44%	-280.0%
Depreciation, Depletion And Amortization	$310.0K	$350.0K
YoY Change	-11.43%	12.9%
Cash From Operating Activities	$420.0K	$500.0K
YoY Change	-16.0%	25.0%
INVESTING ACTIVITIES
Capital Expenditures	$60.00K	$240.0K
YoY Change	-75.0%	9.09%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$130.0K
YoY Change	-100.0%
Cash From Investing Activities	-$60.00K	-$110.0K
YoY Change	-45.45%	-50.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-480.0K	-430.0K
YoY Change	11.63%	514.29%
NET CHANGE
Cash From Operating Activities	420.0K	500.0K
Cash From Investing Activities	-60.00K	-110.0K
Cash From Financing Activities	-480.0K	-430.0K
Net Change In Cash	-120.0K	-40.00K
YoY Change	200.0%	-136.36%
FREE CASH FLOW
Cash From Operating Activities	$420.0K	$500.0K
Capital Expenditures	$60.00K	$240.0K
Free Cash Flow	$360.0K	$260.0K
YoY Change	38.46%	44.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	25918000	USD
CY2013Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	2560000	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	552000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2280000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2470000	USD
CY2013Q3	us-gaap	Goodwill Goodwill	493000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	493000	USD
CY2013Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	168000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	225000	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2013Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	26122000	USD
CY2012Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	2598000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3766000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4009000	USD
CY2013Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	483000	USD
CY2013Q3	us-gaap	Assets Assets	22908000	USD
CY2012Q4	us-gaap	Assets Assets	26303000	USD
CY2013Q3	us-gaap	Line Of Credit LineOfCredit	1185000	USD
CY2012Q4	us-gaap	Line Of Credit LineOfCredit	2244000	USD
CY2013Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	274000	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	277000	USD
CY2013Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	942000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1825000	USD
CY2013Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	676000	USD
CY2012Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	330000	USD
CY2013Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	617000	USD
CY2012Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	617000	USD
CY2013Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	24000	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	24000	USD
CY2013Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	202000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	168000	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3920000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5485000	USD
CY2013Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3959000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4163000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	30000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	30000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1243000	USD
CY2013Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4550000	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	14999000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	16625000	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22908000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26303000	USD
CY2013Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	196000	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	196000	USD
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1101000	shares
CY2013Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2202000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-372000	USD
CY2013Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1621000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1621000	USD
CY2013Q3	us-gaap	Treasury Stock Value TreasuryStockValue	7308000	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	7308000	USD
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8465000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8465000	shares
CY2013Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	2248000	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2248000	shares
CY2013Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6823000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	2273000	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	780000	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	2897000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-624000	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-64000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-688000	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	106000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	373000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	393000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-688000	USD
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6216000	shares
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-55000	USD
	bdr	Proceeds On Sale Of Fixed Assets ProceedsOnSaleOfFixedAssets	0	USD
	bdr	Proceeds On Sale Of Fixed Assets ProceedsOnSaleOfFixedAssets	130000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	101000	USD
	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	0	USD
	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	7020000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-474000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7389000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-1059000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	3496000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1601000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	207000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	197000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1266000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4900000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-399000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-681000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	851000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	170000	USD
	us-gaap	Interest Paid InterestPaid	201000	USD
	us-gaap	Interest Paid InterestPaid	267000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2013Q3	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	1185000	USD
CY2013Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	3152000	USD
	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2015-02-01
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	23618000	USD
	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	-1430000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-1782000	USD
	bdr	Business Acquisition Pro Forma Earnings Per Share Basic And Diluted BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted	-0.29
	us-gaap	Business Acquisition Date Of Acquisition Agreement1 BusinessAcquisitionDateOfAcquisitionAgreement1	2012-02-01
	bdr	Business Acquisition Date Of Acquisition Agreement Amended BusinessAcquisitionDateOfAcquisitionAgreementAmended	2012-02-03
CY2012Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1201000	shares
CY2013Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	5264000	USD
CY2012Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	6493000	USD
CY2013Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	2713000	USD
CY2012Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2950000	USD
CY2013Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5883000	USD
CY2012Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6659000	USD
CY2013Q3	us-gaap	Inventory Gross InventoryGross	13860000	USD
CY2012Q4	us-gaap	Inventory Gross InventoryGross	16102000	USD
CY2013Q3	bdr	Inventory Value Before Reserves InventoryValueBeforeReserves	4541000	USD
CY2012Q4	bdr	Inventory Value Before Reserves InventoryValueBeforeReserves	4783000	USD
CY2013Q3	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	1981000	USD
CY2012Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	2185000	USD
	bdr	Percentage Of Fifo Inventory Non Current For Finished Goods PercentageOfFifoInventoryNonCurrentForFinishedGoods	0.65	pure
CY2012	bdr	Percentage Of Fifo Inventory Non Current For Finished Goods PercentageOfFifoInventoryNonCurrentForFinishedGoods	0.64	pure
CY2008Q3	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	8000000	USD
CY2008	us-gaap	Line Of Credit Facility Increase Decrease Other Net LineOfCreditFacilityIncreaseDecreaseOtherNet	10350000	USD
CY2008	us-gaap	Line Of Credit Facility Covenant Terms LineOfCreditFacilityCovenantTerms	each expiring on February 1, 2015
CY2013Q3	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0325	pure
CY2013Q3	bdr	Line Of Credit Facility Interest Rate Period At One Month LineOfCreditFacilityInterestRatePeriodAtOneMonth	0.0018	pure
CY2013Q3	bdr	Line Of Credit Facility Interest Rate Period At Three Months LineOfCreditFacilityInterestRatePeriodAtThreeMonths	0.0025	pure
CY2013Q3	bdr	Line Of Credit Facility Interest Rate Period At Six Months LineOfCreditFacilityInterestRatePeriodAtSixMonths	0.0037	pure
	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	18000	USD
	us-gaap	Inventory Related Text InventoryRelatedText	Inventories are stated at the lower of cost, determined by the first-in, first-out (FIFO) method, or market.

Files In Submission

Name	View Source	Status
0001144204-13-061383-index-headers.html	Edgar Link	pending
0001144204-13-061383-index.html	Edgar Link	pending
0001144204-13-061383.txt	Edgar Link	pending
0001144204-13-061383-xbrl.zip	Edgar Link	pending
bdr-20130930.xml	Edgar Link	completed
bdr-20130930.xsd	Edgar Link	pending
bdr-20130930_cal.xml	Edgar Link	unprocessable
bdr-20130930_def.xml	Edgar Link	unprocessable
bdr-20130930_lab.xml	Edgar Link	unprocessable
bdr-20130930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v359965_10q.htm	Edgar Link	pending
v359965_ex10-1.htm	Edgar Link	pending
v359965_ex31-1.htm	Edgar Link	pending
v359965_ex31-2.htm	Edgar Link	pending
v359965_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl

2013 Q3 Form 10-Q Financial Statement

#000114420413061383 Filed on November 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDRL BLONDER TONGUE LABORATORIES INC Stock $bdrl

2013 Q3 Form 10-Q Financial Statement

#000114420413061383 Filed on November 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl